Home » Takeda Profit Falls on Cost to Buy Experimental Drugs
Takeda Profit Falls on Cost to Buy Experimental Drugs
Takeda Pharmaceutical Co. posted its first profit drop in five quarters on the cost of acquiring experimental drugs to cope with a sales decline for Actos,
the world’s biggest-selling diabetes medicine.
Bloomberg
Bloomberg
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May